Developer docs
API playgroundTry for free, no card

Search company profiles

LifeWatch

Full company profile

uuid003e7hn

Namestring
LifeWatch
Websiteurl
lifewatch.com
Company typeenum
Private
Founded yearint
1990
Descriptiontext

LifeWatch, founded in 1990 and headquartered in Zug, Switzerland, historically operated as a remote cardiac monitoring and diagnostic services provider listed on the Swiss Exchange under the ticker LIFE (now delisted). The company's core technology footprint spans cardiac ambulatory monitoring solutions including Mobile Cardiac Telemetry (MCOT), Extended Holter patch monitoring (ePatch), and Remote INR monitoring for anticoagulation management, supported by EMR integration capabilities that enable seamless data flow with healthcare systems.

Following its integration trajectory, the cardiac monitoring business operates within the broader Philips-BioTelemetry combined ecosystem, as reflected on the gobio.com platform (BioTelemetry, a Philips Company). This positioning targets the '#1 patient care management ecosystem' across the continuum of care, connecting screening, diagnostic, and patient management solutions spanning home-to-hospital and hospital-to-home workflows. The product suite is structured around clinical care pathways including stroke management, emergency department discharge, and primary care.

The business model centers on direct enterprise sales to hospitals, health systems, and clinical programs on a global basis. Distribution is executed through dedicated field sales targeting enterprise healthcare buyers, with provider portal access (gobio.com) and a patient portal (myheartmonitor.com) supporting clinical decision-making. Historical inorganic growth activity includes the acquisition of FlexLife Health in November 2015 for an undisclosed amount. Customer segments are vertical: healthcare providers and health systems purchasing diagnostic monitoring solutions, with use cases spanning stroke care pathways, ED discharge protocols, and primary care patient management. Revenue mechanics are not publicly disclosed, consistent with a delisted private operating posture under Philips' ownership structure.

Short descriptiontext

LifeWatch is a remote cardiac monitoring and diagnostic services provider, founded 1990 in Zug, Switzerland, now operating within the Philips-BioTelemetry patient care management ecosystem. It serves hospitals and health systems with Mobile Cardiac Telemetry, Extended Holter ePatch, and Remote INR monitoring solutions integrated across stroke, ED discharge, and primary care clinical pathways.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersZug, Switzerland
HQ citystring
Zug
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
remote cardiac monitoring, ambulatory telemetry services, cardiac diagnostics, Holter monitoring services, remote patient monitoring
Industry3 codes
1Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
CodeHLAHACABPrimaryYes
2Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
CodeHLACAPAIPrimaryNo
3Cardiology Telemedicine Platforms
CodeHLALAGABPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Services-Home Health Care Services8082
Product category
Remote Cardiac Monitoring Services
No data
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

LifeWatch is a provider of remote cardiac monitoring diagnostic services, delivering Mobile Cardiac Telemetry (MCOT) for continuous, real-time arrhythmia detection and Extended Holter monitoring through the lightweight ePatch wearable. Services are delivered via the secure goBIO remote patient monitoring platform, integrate with electronic medical records (EMR), and are targeted at clinicians, hospitals, and health systems managing patients outside traditional care settings.

Differentiator
Functional benefit
Problem solved
Product and service3 records
1Mobile Cardiac Telemetry (MCOT)
CategoryRemote cardiac diagnostic monitoring
Description

Continuous, real-time remote cardiac arrhythmia detection and monitoring service for clinicians, hospitals, and health systems managing patients outside traditional care settings.

2Extended Holter Monitoring (ePatch)
CategoryRemote cardiac diagnostic monitoring
Description

Lightweight extended-wear Holter monitoring service delivered via the ePatch wearable, enabling longer ambulatory cardiac monitoring windows for cardiology providers.

3goBIO Remote Patient Monitoring Platform
CategoryRemote patient monitoring software platform
Description

Secure remote patient monitoring platform providing flexible service options for clinical staff and patients, integrating patient-owned data with electronic medical records (EMR).

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthersAnnounced on2021-01-01
Description

Philips works with Giving it Back to Kids, a non-profit organization in Southeast Asia that provides life-saving surgeries and medical care for children with heart disease. This is a charitable partnership focused on pediatric cardiac care in developing regions.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

GE HealthCare provides in-hospital diagnostic cardiology, patient monitoring and ambulatory ECG solutions that overlap LifeWatch's hospital-to-home monitoring strategy across a much wider enterprise portfolio.

TypeBroad incumbent
Description

Abbott's diagnostics and cardiac rhythm management business (including insertable cardiac monitors and remote monitoring via myMerlin) overlaps LifeWatch's ambulatory cardiac monitoring footprint as part of a broad cardiovascular portfolio.

TypeDirect peer
Description

iRhythm's ZIO long-term cardiac monitoring patch competes head-to-head with LifeWatch's Extended Holter (ePatch) and MCOT offerings in ambulatory ECG monitoring, serving the same cardiology and electrophysiology customers.

TypeBroad incumbent
Description

Through its Preventice acquisition and broader cardiology franchise, Boston Scientific offers ambulatory ECG and remote cardiac monitoring capabilities overlapping LifeWatch's patch and MCOT services.

TypeDirect peer
Description

Preventice's BodyGuardian remote cardiac monitoring portfolio directly overlaps LifeWatch's MCOT and patch offerings; following Boston Scientific's acquisition, it competes across the same health-system channel.

TypeBroad incumbent
Description

Medtronic offers insertable cardiac monitors (Reveal LINQ) and broader diagnostics and monitoring across the cardiology continuum, competing with LifeWatch from a much larger, multi-product portfolio.

TypeEmerging player
Description

Spacelabs provides ambulatory Holter and cardiac telemetry products alongside its patient monitoring portfolio, making it a partial-overlap competitor focused on certain hospital and cardiology segments rather than a full MCOT + patch stack.

TypeBroad incumbent
Description

Philips acquired BioTelemetry (which absorbed LifeWatch) and now sells the MCOT and ePatch offerings as part of its Connected Care and diagnostic cardiology portfolios, supplying the enterprise channel LifeWatch leverages.

TypeDirect peer
Description

Bardy's CAM (Cardiac Ambulatory Monitor) patch is a direct competitor to LifeWatch's ePatch and MCOT in ambulatory ECG rhythm monitoring for cardiology and electrophysiology customers.

TypeDirect peer
Description

BioTelemetry operates the MCOT and ePatch services that LifeWatch is now folded into, sharing identical cardiac ambulatory monitoring technology stack and direct sales motion to hospitals and cardiology practices.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LifeWatch

Remote Cardiac Monitoring Serviceslifewatch.com

LifeWatch is a remote cardiac monitoring and diagnostic services provider, founded 1990 in Zug, Switzerland, now operating within the Philips-BioTelemetry patient care management ecosystem. It serves hospitals and health systems with Mobile Cardiac Telemetry, Extended Holter ePatch, and Remote INR monitoring solutions integrated across stroke, ED discharge, and primary care clinical pathways.

What LifeWatch does

LifeWatch, founded in 1990 and headquartered in Zug, Switzerland, historically operated as a remote cardiac monitoring and diagnostic services provider listed on the Swiss Exchange under the ticker LIFE (now delisted). The company's core technology footprint spans cardiac ambulatory monitoring solutions including Mobile Cardiac Telemetry (MCOT), Extended Holter patch monitoring (ePatch), and Remote INR monitoring for anticoagulation management, supported by EMR integration capabilities that enable seamless data flow with healthcare systems.

Following its integration trajectory, the cardiac monitoring business operates within the broader Philips-BioTelemetry combined ecosystem, as reflected on the gobio.com platform (BioTelemetry, a Philips Company). This positioning targets the '#1 patient care management ecosystem' across the continuum of care, connecting screening, diagnostic, and patient management solutions spanning home-to-hospital and hospital-to-home workflows. The product suite is structured around clinical care pathways including stroke management, emergency department discharge, and primary care.

The business model centers on direct enterprise sales to hospitals, health systems, and clinical programs on a global basis. Distribution is executed through dedicated field sales targeting enterprise healthcare buyers, with provider portal access (gobio.com) and a patient portal (myheartmonitor.com) supporting clinical decision-making. Historical inorganic growth activity includes the acquisition of FlexLife Health in November 2015 for an undisclosed amount. Customer segments are vertical: healthcare providers and health systems purchasing diagnostic monitoring solutions, with use cases spanning stroke care pathways, ED discharge protocols, and primary care patient management. Revenue mechanics are not publicly disclosed, consistent with a delisted private operating posture under Philips' ownership structure.

LifeWatch firmographics

Firmographics
Name
LifeWatch
Website
https://lifewatch.com
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
11–50 employees
Short description
LifeWatch is a remote cardiac monitoring and diagnostic services provider, founded 1990 in Zug, Switzerland, now operating within the Philips-BioTelemetry patient care management ecosystem. It serves hospitals and health systems with Mobile Cardiac Telemetry, Extended Holter ePatch, and Remote INR monitoring solutions integrated across stroke, ED discharge, and primary care clinical pathways.
Ownership category
akta.pro rank

LifeWatch industry classification

Industry
Product category
Remote Cardiac Monitoring Services
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Services-Home Health Care Services (8082)
akta.pro primary industry
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
akta.pro secondary industries
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Cardiology Telemedicine Platforms (HLALAGAB)

Keywords

  • Remote cardiac monitoring
  • Ambulatory telemetry services
  • Cardiac diagnostics
  • Holter monitoring services
  • Remote patient monitoring

Where LifeWatch is headquartered

Location

Headquarters

HQ city
Zug
HQ country
Switzerland
HQ region
Europe

Markets served

LifeWatch business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Distribution channels2 records

Marketing channels3 records

LifeWatch product offering

Product offering

Core offering

LifeWatch is a provider of remote cardiac monitoring diagnostic services, delivering Mobile Cardiac Telemetry (MCOT) for continuous, real-time arrhythmia detection and Extended Holter monitoring through the lightweight ePatch wearable. Services are delivered via the secure goBIO remote patient monitoring platform, integrate with electronic medical records (EMR), and are targeted at clinicians, hospitals, and health systems managing patients outside traditional care settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Mobile Cardiac Telemetry (MCOT) Continuous, real-time remote cardiac arrhythmia detection and monitoring service for clinicians, hospitals, and health systems managing patients outside traditional care settings.
  • Extended Holter Monitoring (ePatch) Lightweight extended-wear Holter monitoring service delivered via the ePatch wearable, enabling longer ambulatory cardiac monitoring windows for cardiology providers.
  • goBIO Remote Patient Monitoring Platform Secure remote patient monitoring platform providing flexible service options for clinical staff and patients, integrating patient-owned data with electronic medical records (EMR).

Companies that use LifeWatch

Customer profile

Segments2 records

Ideal customer profiles1 record

LifeWatch technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

LifeWatch partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Giving it Back to KidsminorOthers · 1 January 2021Philips works with Giving it Back to Kids, a non-profit organization in Southeast Asia that provides life-saving surgeries and medical care for children with heart disease. This is a charitable partnership focused on pediatric cardiac care in developing regions.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

LifeWatch competitors and assessment

Company assessment

Broad incumbents

  • GE HealthCare: GE HealthCare provides in-hospital diagnostic cardiology, patient monitoring and ambulatory ECG solutions that overlap LifeWatch's hospital-to-home monitoring strategy across a much wider enterprise portfolio.
  • Abbott: Abbott's diagnostics and cardiac rhythm management business (including insertable cardiac monitors and remote monitoring via myMerlin) overlaps LifeWatch's ambulatory cardiac monitoring footprint as part of a broad cardiovascular portfolio.
  • Boston Scientific: Through its Preventice acquisition and broader cardiology franchise, Boston Scientific offers ambulatory ECG and remote cardiac monitoring capabilities overlapping LifeWatch's patch and MCOT services.
  • Medtronic: Medtronic offers insertable cardiac monitors (Reveal LINQ) and broader diagnostics and monitoring across the cardiology continuum, competing with LifeWatch from a much larger, multi-product portfolio.
  • Philips: Philips acquired BioTelemetry (which absorbed LifeWatch) and now sells the MCOT and ePatch offerings as part of its Connected Care and diagnostic cardiology portfolios, supplying the enterprise channel LifeWatch leverages.

Direct peers

  • iRhythm Technologies: iRhythm's ZIO long-term cardiac monitoring patch competes head-to-head with LifeWatch's Extended Holter (ePatch) and MCOT offerings in ambulatory ECG monitoring, serving the same cardiology and electrophysiology customers.
  • Preventice Solutions (Boston Scientific): Preventice's BodyGuardian remote cardiac monitoring portfolio directly overlaps LifeWatch's MCOT and patch offerings; following Boston Scientific's acquisition, it competes across the same health-system channel.
  • Bardy Diagnostics (Hillrom / Baxter): Bardy's CAM (Cardiac Ambulatory Monitor) patch is a direct competitor to LifeWatch's ePatch and MCOT in ambulatory ECG rhythm monitoring for cardiology and electrophysiology customers.
  • BioTelemetry (Philips subsidiary): BioTelemetry operates the MCOT and ePatch services that LifeWatch is now folded into, sharing identical cardiac ambulatory monitoring technology stack and direct sales motion to hospitals and cardiology practices.

Emerging players

  • Spacelabs Healthcare: Spacelabs provides ambulatory Holter and cardiac telemetry products alongside its patient monitoring portfolio, making it a partial-overlap competitor focused on certain hospital and cardiology segments rather than a full MCOT + patch stack.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

LifeWatch financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LifeWatch leadership team

Management profile

Number of profiles

Profiles2 records

LifeWatch funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LifeWatch M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeWatch

What does LifeWatch do?

LifeWatch is a provider of remote cardiac monitoring diagnostic services, delivering Mobile Cardiac Telemetry (MCOT) for continuous, real-time arrhythmia detection and Extended Holter monitoring through the lightweight ePatch wearable. Services are delivered via the secure goBIO remote patient monitoring platform, integrate with electronic medical records (EMR), and are targeted at clinicians, hospitals, and health systems managing patients outside traditional care settings.

Is LifeWatch a public or private company?

LifeWatch is a private company. It is classified as unknown and is currently operating.

When was LifeWatch founded?

LifeWatch was founded in 1990. It employs 11 to 50 people.

Where is LifeWatch based?

LifeWatch is headquartered in Zug, Switzerland, in the Europe region.

Who are LifeWatch's main competitors?

Broad incumbents on record are GE HealthCare, Abbott, Boston Scientific, Medtronic and Philips. Direct peers are iRhythm Technologies, Preventice Solutions (Boston Scientific), Bardy Diagnostics (Hillrom / Baxter) and BioTelemetry (Philips subsidiary). Spacelabs Healthcare is listed as an emerging player.

Does LifeWatch have an API?

No public API is recorded for LifeWatch.

What industry is LifeWatch in?

LifeWatch's product category is Remote Cardiac Monitoring Services. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGlobal mHealth market is projected to attain a size of $132.2 billion by 2023P&S Market Research projects the global mHealth market to reach $132.2 billion by 2023, driven by increasing smartphone penetration, rising connected medical device adoption, and growing healthcare costs. The mHealth apps segment is expected to witness the fastest growth at a CAGR of 38.9%, while North America held the largest regional market share at 37.8% in 2017. As part of market consolidation, BioTelemetry Inc. acquired LifeWatch AG in July 2017 to strengthen its position in remote cardiac monitoring and diagnostic services.GlobeNewswireBioTelemetry, Inc. Completes LifeWatch AG AcquisitionBioTelemetry completed its acquisition of LifeWatch AG, a Swiss healthcare technology company. The deal strengthens BioTelemetry's position in wireless medicine and remote cardiac monitoring. The company will focus on combining both companies' strengths and expanding into chronic care sectors.GlobeNewswireLifeWatch’s Largest Shareholders Accept BioTelemetry, Inc.’s Tender Offer for LifeWatch AGBioTelemetry announced a tender offer for LifeWatch AG, with major shareholders pledging support and agreeing to tender shares. The offer provides CHF10 cash plus 0.1617 BioTelemetry shares per LifeWatch share, totaling about CHF269 million. The main offer period ends June 8, 2017, with an extension expected to June 28.GlobeNewswireBioTelemetry, Inc. Announces the Start of the Tender Offer Period for LifeWatch AG SharesBioTelemetry, Inc. began its tender offer to acquire all LifeWatch AG shares, with the main offer period expiring May 23, 2017. Shareholders receive CHF 10 cash plus 0.1457 BioTelemetry shares (CHF 14.34 total) or CHF 8 cash plus 0.2185 shares (CHF 14.51 total). The deal value increased to CHF 265-268 million from CHF 259 million.GlobeNewswireBioTelemetry, Inc. Announces Receipt of Antitrust Clearance for its Acquisition of LifeWatch AGBioTelemetry received early termination of the HSR waiting period for its tender offer to acquire LifeWatch AG, effective May 5, 2017, without conditions. The transaction is expected to close in the third quarter of 2017, subject to other closing conditions.GlobeNewswireBioTelemetry, Inc. Issues Prospectus for Public Tender Offer to Acquire LifeWatch AGBioTelemetry published a prospectus for a public tender offer to acquire all publicly held LifeWatch AG shares. Shareholders receive CHF10 cash plus 0.1457 BioTelemetry shares (CHF4 per LifeWatch share) or CHF8 cash plus 0.2185 shares (CHF6 per LifeWatch share), with a total deal value of about CHF260 million. The offer period runs from May 10 to May 23, 2017.PR NewswireLifeWatch Discloses Supplemental Information on Highmark Arbitration CaseAn arbitrator from the International Centre for Dispute Resolution ruled on March 16, 2016, that LifeWatch Services, Inc., a subsidiary of LifeWatch AG, is liable for approximately $18.7 million in damages plus interest to Highmark Blue Cross Blue Shield in a dispute over payment for ACT telemetry monitoring services for the years 2009-2010. LifeWatch stated it will vigorously pursue post-arbitration options, including seeking to vacate the award and pursuing a related antitrust case against Highmark, other Blue Cross Blue Shield entities, and the Blue Cross Blue Shield National Association for their collective refusal to cover ACT telemetry services. The company maintains its underlying operational health remains strong despite the adverse arbitration decision.PR NewswireLifeWatch™ Receives FDA Clearance for Its Continuous Vital Signs Monitoring ServiceLifeWatch AG, a Swiss medical technology company listed on SIX Swiss Exchange, announced it has received FDA clearance for its wireless, patch-based Vital Signs Monitoring Service designed for continuous non-invasive monitoring of vital signs including ECG, heart rate, respiration rate, temperature, blood oxygen saturation, and body position. The system, intended for adult patients in clinical environments, will initially launch in hospitals and nursing homes before expanding to the ambulatory market, though the company acknowledges this clinical market entry will require additional time and resources. CEO Dr. Stephan Rietiker highlighted the technology's market potential and cost benefits that could enable vital signs monitoring for a broader patient population worldwide.PR NewswireAliveCor Partners with LifeWatch to Expand Into Remote Patient MonitoringAliveCor, Inc. announced a strategic partnership with LifeWatch AG to integrate its FDA-cleared Mobile ECG device into LifeWatch's remote cardiac monitoring service, marking AliveCor's first expansion into the remote patient monitoring market. The integration will enable healthcare providers to remotely monitor high-risk cardiac patients outside traditional care settings while allowing patients to access real-time heart health data. LifeWatch, a Swiss-listed healthcare technology company with operations in the United States, Switzerland, and Israel, will use the AliveCor Mobile ECG to broaden its cardiac event monitoring services.PR NewswireLifeWatch AG Signs Agreement With AliveCor, Inc.LifeWatch AG signed an agreement with AliveCor Inc. to integrate the AliveCor Mobile ECG technology into its cardiac monitoring product offering. The partnership will enable LifeWatch to expand its cardiac event monitoring services and offer patients greater control through their own mobile devices, while AliveCor gains access to the remote patient monitoring market. Both CEOs commented on the strategic fit, with Dr. Stephan Rietiker highlighting the technology's innovative capabilities and Vic Gundotra emphasizing the broader impact on patient care.